Dr. Rogers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2009
Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
Harvard Medical SchoolClass of 2001
Certifications & Licensure
CA State Medical License 2013 - 2025
MA State Medical License 2004 - 2015- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START) Start of enrollment: 2014 Mar 15
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol Start of enrollment: 2021 Apr 23
Publications & Presentations
PubMed
- International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium.Andrew R Moore, Hong Zheng, Ananthakrishnan Ganesan, Yehudit Hasin-Brumshtein, Manoj V Maddali
Biorxiv. 2024-11-15 - Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19.Cavan Reilly, Eleftherios Mylonakis, Robin Dewar, Barnaby Young, Jacqueline Nordwall
The Journal of Infectious Diseases. 2024-09-12 - 1 citationsMolecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts.Manoj V Maddali, Andrew R Moore, Pratik Sinha, Chad A Newton, John S Kim
American Journal of Respiratory and Critical Care Medicine. 2024-08-15
Press Mentions
Test Predicts Which COVID-19 Patients Will Grow Worse, Stanford Medicine Study FindSeptember 26th, 2022- The Proof Is in the Plasma: SARS-CoV-2 Antigen Levels Predict SeverityAugust 30th, 2022
- Scientists Decipher the Danger of Gummy Phlegm in Severe COVID-19June 24th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
